Monitoring of medical literature and the entry of relevant information into the EudraVigilance datab
The literature subject to the monitoring activities by the Agency as outlined above has been defined in accordance with the provisions set out in the Good Pharmacovigilance Practices (GVP) guideline, Module VI 'Management and reporting of adverse reactions to medicinal products' and is based on the use of literature reference databases. A description of these literature reference databases including their journal coverage is provided.
